Ketamine failed to outweigh the active placebo for depression
in A new study from Stanford UniversityWhen the researchers compared intravenous ketamine with an active placebo, the supposed rapid antidepressant effect of ketamine disappeared. Medication failed to beat placebo for treating depression. “A single dose of intravenous ketamine compared with placebo had no short-term effect on the severity of depressive symptoms in adults with major … Read more